Blocking the TLR4–MD2 complex could reduce blood pressure and improve vascular damage in type 1 diabetes mouse models; however, whether this is effective in type 2 diabetes requires further research.[41] LY96 participating in various biological pathways is interrelated to the activation and regulation of innate immune responses. The gene discussed is TLR4; the disease is type 2 diabetes mellitus.